A nomogram to estimate the HbA1c response to different DPP-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients

Predictive and Explanatory Factors of Change in HbA1cin a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs

(2014) Philip D. Home et al.   DIABETES CARE

Improved real-world glycaemic outcomes with liraglutide versus other incretin-based therapies in type 2 diabetes

(2014) W. C. Lee et al.   DIABETES OBESITY & METABOLISM

Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies

(2014) Bo Ahrén et al.   DIABETOLOGIA

Glycaemic durability with dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of long-term randomised controlled trials

(2014) K. Esposito et al.   BMJ Open

Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study

(2014) Dominique Simon et al.   Diabetes Therapy

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2013) Alessandro Liberati   ANNALS OF INTERNAL MEDICINE

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert Forum

(2013) I. Raz et al.   DIABETES CARE

Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis

(2013) S. H. Golden et al.   DIABETES CARE

Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012

(2013) Lydia W. Turner et al.   DIABETES CARE

Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

(2013) D. M. Nathan et al.   DIABETES CARE

Standards of Medical Care in Diabetes--2014

(2013)   DIABETES CARE

Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real-life worldwide observational study (EDGE)

(2013) C. Mathieu et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

When Metformin Fails in Type 2 Diabetes Mellitus

(2011) Katherine Esposito et al.   ARCHIVES OF INTERNAL MEDICINE

Dipeptidyl peptidase-4 inhibitors and HbA1c target of

(2011) K. Esposito et al.   DIABETES OBESITY & METABOLISM

Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials

(2011) Matteo Monami et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Pragmatic Trials — Guides to Better Patient Care?

(2011) James H. Ware et al.   NEW ENGLAND JOURNAL OF MEDICINE

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal